Are Options Traders Bullish on BGNE?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About BGNE

BeiGene is a global, clinical-stage, research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapeutics. With a team of over 300 scientists, clinicians and staff in mainland China, the United States, Australia and Taiwan, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is working to create combination solutions aimed to have both a meaningful and lasting impact on cancer patients.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

BGNE is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ADRA Invesco BLDRS Asia 50 ADR Index Fund 17.8 M 1.78E+07 50 50 0.47% 0.00467 84 K 83960
ADRE Invesco BLDRS Emerging Markets 50 ADR Index Fund 128.2 M 1.282E+08 50 50 0.56% 0.0056 730 K 729857
BIB ProShares Ultra Nasdaq Biotechnology 283.8 M 2.83842E+08 202 202 0.3% 0.00295996 1.7 M 1741740
IBB iShares Nasdaq Biotechnology Index Fund 8.0 B 8.00963E+09 191 191 0.66% 0.0066 54.2 M 5.42366E+07
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.03% 0.000310531 575 K 574639
UBIO Proshares UltraPro Nasdaq Biotechnology 28.8 M 2.87594E+07 196 196 0.14% 0.00138978 132 K 132163

Wait, Before You Leave...